Lisheng Wang

605 total citations
20 papers, 387 citations indexed

About

Lisheng Wang is a scholar working on Oncology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisheng Wang has authored 20 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisheng Wang's work include Nutrition and Health in Aging (4 papers), CAR-T cell therapy research (3 papers) and Cancer survivorship and care (3 papers). Lisheng Wang is often cited by papers focused on Nutrition and Health in Aging (4 papers), CAR-T cell therapy research (3 papers) and Cancer survivorship and care (3 papers). Lisheng Wang collaborates with scholars based in China, Macao and Canada. Lisheng Wang's co-authors include Wenbo Nie, Tianxin Xu, Fengjun Xiao, Yuxiang Li, Aimei Zhang, Lin Du, Li Chen, Xinxin Wang, Chu-Tse Wu and Lijing Zhao and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and International Journal of Pharmaceutics.

In The Last Decade

Lisheng Wang

18 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisheng Wang China 10 147 73 55 52 51 20 387
Wenbo Nie China 10 86 0.6× 30 0.4× 79 1.4× 37 0.7× 69 1.4× 21 493
Karen Thudium Mueller United States 11 395 2.7× 86 1.2× 195 3.5× 99 1.9× 62 1.2× 39 697
Delyth Morris United Kingdom 10 77 0.5× 13 0.2× 43 0.8× 14 0.3× 20 0.4× 13 592
Elizabeth Tkachenko United States 13 83 0.6× 29 0.4× 91 1.7× 9 0.2× 91 1.8× 34 555
Sharon Richardson United States 10 24 0.2× 94 1.3× 40 0.7× 37 0.7× 87 1.7× 18 484
Khaled Mohamed Ragab Egypt 12 28 0.2× 18 0.2× 49 0.9× 32 0.6× 23 0.5× 42 344
Kelly Harper United States 12 31 0.2× 34 0.5× 79 1.4× 49 0.9× 48 0.9× 28 392
Martin Goros United States 12 31 0.2× 35 0.5× 99 1.8× 16 0.3× 61 1.2× 27 420
Zhonghui Wang China 11 27 0.2× 51 0.7× 112 2.0× 23 0.4× 64 1.3× 34 402
Karen Byrne United States 11 34 0.2× 63 0.9× 59 1.1× 22 0.4× 13 0.3× 12 532

Countries citing papers authored by Lisheng Wang

Since Specialization
Citations

This map shows the geographic impact of Lisheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisheng Wang more than expected).

Fields of papers citing papers by Lisheng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisheng Wang. The network helps show where Lisheng Wang may publish in the future.

Co-authorship network of co-authors of Lisheng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lisheng Wang. A scholar is included among the top collaborators of Lisheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisheng Wang. Lisheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Jingyuan, et al.. (2025). Colorectal Cancer: Pathogenesis and Targeted Therapy. MedComm. 6(3). e70127–e70127. 10 indexed citations
3.
Du, Shuang, Kui Wu, Yucheng Guan, et al.. (2025). Biomimetic celastrol nanocrystals with enhanced efficacy and reduced toxicity for suppressing breast cancer invasion and metastasis. International Journal of Pharmaceutics. 671. 125221–125221. 1 indexed citations
4.
Wang, Yiming, et al.. (2024). Development and validation of machine learning models for predicting cancer-related fatigue in lymphoma survivors. International Journal of Medical Informatics. 192. 105630–105630. 1 indexed citations
6.
Li, Wen, et al.. (2024). Luteolin target HSPB1 regulates endothelial cell ferroptosis to protect against radiation vascular injury. PLoS ONE. 19(10). e0311922–e0311922. 4 indexed citations
7.
Li, Guichen, Xinxin Wang, Wei Liu, et al.. (2024). Prevalence of multidimensional frailty among community-dwelling older adults: A systematic review and meta-analysis. International Journal of Nursing Studies. 154. 104755–104755. 13 indexed citations
8.
Ma, Xiaoxuan, Jian Jiang, Chi Ma, et al.. (2023). Advances in research based on antibody-cell conjugation. Frontiers in Immunology. 14. 1310130–1310130. 1 indexed citations
10.
Wang, Yiming, Xia Liu, Hao Zhang, et al.. (2023). Multidimensional Predictors of Cancer-Related Fatigue Based on the Predisposing, Precipitating, and Perpetuating (3P) Model: A Systematic Review. Cancers. 15(24). 5879–5879. 7 indexed citations
11.
Xu, Tianxin, et al.. (2023). Machine learning in predicting outcomes for stroke patients following rehabilitation treatment: A systematic review. PLoS ONE. 18(6). e0287308–e0287308. 10 indexed citations
12.
Chen, Mengmeng, Jian Jiang, Junyu Chen, et al.. (2023). The Clinical Safety and Efficacy of Targeted PD-L1 Therapy with Durvalumabin Solid Tumors. Current Drug Targets. 24(7). 584–598. 3 indexed citations
13.
Zhang, Lin, Xiaoxu Zhang, Yubin Liu, et al.. (2022). Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure. Stem Cell Research & Therapy. 13(1). 267–267. 24 indexed citations
14.
Du, Lin, et al.. (2022). Blended learning vs traditional teaching: The potential of a novel teaching strategy in nursing education - a systematic review and meta-analysis. Nurse Education in Practice. 63. 103354–103354. 63 indexed citations
15.
Wang, Taiwei, Tianxin Xu, Lin Du, et al.. (2022). A bibliometric analysis of global publications on graft-versus-host disease research. Medicine. 101(27). e29634–e29634. 3 indexed citations
16.
Zhang, Dan, et al.. (2022). Psychometric properties of the Chinese version of the attitude towards pressure ulcer prevention instrument: A cross‐sectional survey. International Wound Journal. 19(8). 2019–2030. 1 indexed citations
17.
Li, Yuxiang, Fengjun Xiao, Aimei Zhang, et al.. (2020). Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer. Cellular Immunology. 348. 104041–104041. 69 indexed citations
18.
Nie, Wenbo, Ping Xu, Chunyan Hao, et al.. (2020). Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea. Medicine. 99(19). e19881–e19881. 37 indexed citations
19.
Wang, Shuo, Huiru Yin, Xinxin Wang, et al.. (2019). Efficacy of different types of exercises on global cognition in adults with mild cognitive impairment: a network meta-analysis. Aging Clinical and Experimental Research. 31(10). 1391–1400. 58 indexed citations
20.
Wei, Jing, Huiyan Sun, Aimei Zhang, et al.. (2018). A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers. Cellular Immunology. 331. 49–58. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026